LOS ANGELES, CA--(Marketwired - Apr 27, 2015) - MIT Holding Inc. (OTCQB: MITD) is pleased to announce that it has achieved positive net income from operations in 2014. For the year ended December 31, 2014, the Company reported net income from operations of $14,152 compared to a net loss from operations of ($1,123,830) for the same period a year earlier. This increase in net income from operations of $1,137,982 can be attributed to the Company's overall restructuring efforts and renewed focus on its in home health recovery business. The Company's complete Form 10-K is available at www.sec.gov.

"Our in-home health recovery business, which facilitates and assists patients from the time of their release from a hospital through to a full in-home recovery, is now in place," commented Mr. Tommy Duncan, President of MIT Holding. "This was an area of significant focus in our restructuring efforts and which led to our financial turnaround in 2014. We look for continued growth in this business in 2015."

Demand for low cost, high quality home care will only increase as payers realize up to 90% saving on infusion services performed in the home versus in the hospital. According to Harris Williams & Co, the United States home infusion market is $15.9 billion and is expected to reach $26.7 billion by 2020, resulting in a compound annual growth rate of 9.02% per year. 

Mr. Duncan further commented, "Our target audience is focused on those needing infusion for recovery. Many infusion therapies cost more than $10,000 per patient, per year. Patients receiving treatment usually require special counseling and education regarding their condition and treatment. Retail pharmacies and other traditional distributors generally are designed to carry inventories of low cost, high volume products. Our platform is based on the delivery of these high cost, low volume specialty pharmaceuticals that have specialized handling and administration requirements."

For further information click the following:
Click here for recent news on MITD
Click here for current SEC filings for MITD

About MIT Holding, Inc.
MIT Holding offers through its portfolio of licenses, contractual and affiliate agreements, a single source provider of medical concierge services and products. Currently including but not limited to; administering intravenous infusions, medical management services, in home therapies. MIT is now operating nationwide. For more information, visit http://mitholdinginc.com.

Forward-Looking Statements
 This news release contains "forward-looking statements" as defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, there can be no assurance that such beliefs, plans, expectations, intentions will prove to be accurate.